Alterations in body weight and biochemistry in patient treated with different psychotropic drugs in a clinic in Istanbul

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.

  2006cited by this paper
• Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease

  2005cited by this paper
• The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease.

  2004cited by this paper
• Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis.

  2004cited by this paper
• Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.

  2004cited by this paper
• The metabolic syndrome, inflammation, and risk of cognitive decline.

  2004cited by this paper
• Cardiovascular risk factors and Alzheimer’s disease

  2004cited by this paper
• [Prevention of dementia (including Alzheimer's disease)].

  2004cited by this paper
• Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

  2003cited by this paper
• Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.

  2002cited by this paper
• Antipsychotic-associated weight gain and clinical outcome parameters.

  2001cited by this paper
• Antipsychotic-induced weight gain: a review of the literature.

  2001cited by this paper
• Epidemiology, morbidity, and treatment of overweight and obesity.

  2001cited by this paper
• The role of antidepressants in the treatment of abdominal obesity.

  2000cited by this paper
• The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke

  2000cited by this paper
• Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-α and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine

  2000cited by this paper
• Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

  1999cited by this paper
• Blood pressure in relation to obesity, insulin and the hypothalamic‐pituitary‐adrenal axis in Swedish men

  1998cited by this paper
• Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity.

  1998cited by this paper
• Weight gain induced by clozapine.

  1995cited by this paper
• Lithium and Body Weight Gain

  1995cited by this paper
• Weight gain with antidepressants and lithium.

  1988cited by this paper
• WEIGHT CHANGES IN LITHIUM RESPONDERS

  1970cited by this paper
• Weight as a correlate of clinical response to psychotropic drugs.

  1970cited by this paper
• Weight changes during treatment with phenothiazine derivatives.

  1960cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Stress-Related Cortisol Secretion in Men: Relationships with Abdominal Obesity and Endocrine, Metabolic and

  year unknowncited by this paper

• No citing papers are available for this paper.